For example, in mice that are tumor-prone due to heterozygous loss of PTEN combined with reduced expression of LKB1, development of tumors (mostly lymphomas) can be delayed by treating the mice from the time of weaning with metformin or phenformin, or by another AMPK activator, A-769662 [79]. This evidence concerns the gene PRKAA1 and lymphoma.